Naples Money Management »

Halozyme Therapeutics shares owned by Naples Money Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Naples Money Management from 13F filings

Historical chart of Naples Money Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Naples Money Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Naples Money Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.9k 50 57.24

More positions owned by Naples Money Management

Spdr S&p 500 Etf Trust Etf (SPY)
Nvidia Corporation Stock (NVDA)
Netflix Stock (NFLX)
Microsoft Corp Stock (MSFT)
Teradyne Stock (TER)
Carpenter Technology Corp Stock (CRS)
Meta Platforms Inc Cl A Stock (META)
Capital One Finl Corp Stock (COF)
L3harris Technologies Stock (LHX)
Walmart Stock (WMT)
Chubb Stock (CB)
M & T Bk Corp Stock (MTB)
Nextera Energy Stock (NEE)
Royal Caribbean Group Stock (RCL)
Quest Diagnostics Stock (DGX)

View all positions for Naples Money Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics